Cargando…
Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by beta-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has rapidly spread across the globe starting from February 2020. It is well established that during viral infection, extracellular vesicles become...
Autores principales: | Pesce, Elisa, Manfrini, Nicola, Cordiglieri, Chiara, Santi, Spartaco, Bandera, Alessandra, Gobbini, Andrea, Gruarin, Paola, Favalli, Andrea, Bombaci, Mauro, Cuomo, Alessandro, Collino, Federica, Cricrì, Giulia, Ungaro, Riccardo, Lombardi, Andrea, Mangioni, Davide, Muscatello, Antonio, Aliberti, Stefano, Blasi, Francesco, Gori, Andrea, Abrignani, Sergio, De Francesco, Raffaele, Biffo, Stefano, Grifantini, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801440/ https://www.ncbi.nlm.nih.gov/pubmed/35111156 http://dx.doi.org/10.3389/fimmu.2021.785941 |
Ejemplares similares
-
The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study
por: Favalli, Ennio Giulio, et al.
Publicado: (2022) -
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study
por: Favalli, Ennio Giulio, et al.
Publicado: (2022) -
Comments on “PD-1 Inhibitor for Disseminated Mycobacterium avium Infection in a Person Living With HIV”
por: Lombardi, Andrea, et al.
Publicado: (2023) -
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation
por: Pagani, Lisa, et al.
Publicado: (2023) -
Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2
por: Miluzio, Annarita, et al.
Publicado: (2022)